Correlation Between Cingulate Warrants and Pliant Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Pliant Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Pliant Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and Pliant Therapeutics, you can compare the effects of market volatilities on Cingulate Warrants and Pliant Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Pliant Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Pliant Therapeutics.
Diversification Opportunities for Cingulate Warrants and Pliant Therapeutics
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cingulate and Pliant is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Pliant Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pliant Therapeutics and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Pliant Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pliant Therapeutics has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Pliant Therapeutics go up and down completely randomly.
Pair Corralation between Cingulate Warrants and Pliant Therapeutics
Assuming the 90 days horizon Cingulate Warrants is expected to generate 6.04 times more return on investment than Pliant Therapeutics. However, Cingulate Warrants is 6.04 times more volatile than Pliant Therapeutics. It trades about -0.01 of its potential returns per unit of risk. Pliant Therapeutics is currently generating about -0.12 per unit of risk. If you would invest 5.79 in Cingulate Warrants on August 24, 2024 and sell it today you would lose (2.02) from holding Cingulate Warrants or give up 34.89% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
Cingulate Warrants vs. Pliant Therapeutics
Performance |
| Timeline |
| Cingulate Warrants |
| Pliant Therapeutics |
Cingulate Warrants and Pliant Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cingulate Warrants and Pliant Therapeutics
The main advantage of trading using opposite Cingulate Warrants and Pliant Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Pliant Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pliant Therapeutics will offset losses from the drop in Pliant Therapeutics' long position.| Cingulate Warrants vs. Lyra Therapeutics | Cingulate Warrants vs. Hookipa Pharma | Cingulate Warrants vs. SAB Biotherapeutics | Cingulate Warrants vs. Cadrenal Therapeutics, Common |
| Pliant Therapeutics vs. Lyra Therapeutics | Pliant Therapeutics vs. Hookipa Pharma | Pliant Therapeutics vs. Cingulate Warrants | Pliant Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |